Select Medical (NYSE:SEM) Issues FY 2021 Earnings Guidance

Select Medical (NYSE:SEM) issued an update on its FY 2021 earnings guidance on Thursday morning. The company provided EPS guidance of $2.980-$3.090 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.030. The company issued revenue guidance of $6.05 billion-$6.15 billion, compared to the consensus revenue estimate of $5.99 billion.

Select Medical stock traded down $0.18 during trading hours on Thursday, reaching $30.19. The company had a trading volume of 474,920 shares, compared to its average volume of 687,541. The company has a debt-to-equity ratio of 2.48, a current ratio of 1.34 and a quick ratio of 1.34. The company has a 50-day moving average price of $33.98 and a 200 day moving average price of $36.81. The firm has a market cap of $4.05 billion, a price-to-earnings ratio of 9.49, a P/E/G ratio of 0.75 and a beta of 1.23. Select Medical has a 12-month low of $23.91 and a 12-month high of $43.60.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, November 4th. The health services provider reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.05. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.44 billion. Select Medical had a return on equity of 31.74% and a net margin of 7.04%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period last year, the company earned $0.56 EPS. As a group, research analysts expect that Select Medical will post 3.05 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 29th. Stockholders of record on Tuesday, November 16th will be given a $0.125 dividend. The ex-dividend date is Monday, November 15th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.66%. Select Medical’s dividend payout ratio is currently 15.72%.

Separately, Credit Suisse Group lifted their price objective on Select Medical from $37.00 to $39.00 and gave the stock a neutral rating in a research report on Tuesday, August 10th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from, the stock presently has a consensus rating of Buy and an average target price of $42.20.

An institutional investor recently raised its position in Select Medical stock. LPL Financial LLC lifted its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 6.8% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,572 shares of the health services provider’s stock after purchasing an additional 676 shares during the quarter. LPL Financial LLC’s holdings in Select Medical were worth $382,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 76.30% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility.

Featured Story: SEC Filing

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with's FREE daily email newsletter.